Total, No. (%)d | PR (95% CI) | aPRf (95% CI) | ||
---|---|---|---|---|
Total | 14,961 (100) | 3,362 (22.5) | ||
Age, years | ||||
15–24 | 1,508 (10.1) | 345 (22.9) | 0.99 (0.88, 1.11) | 0.93 (0.83, 1.04) |
25–34 | 1,798 (12.0) | 405 (22.5) | 0.97 (0.87, 1.08) | 0.91 (0.82, 1.02) |
35–44 | 2,786 (18.6) | 646 (23.2) | Ref | Ref |
45–54 | 3,683 (24.6) | 851 (23.1) | 1.00 (0.91, 1.09) | 1.02 (0.93, 1.11) |
55–64 | 3,215 (21.5) | 714 (22.2) | 0.96 (0.87, 1.05) | 1.00 (0.91, 1.10) |
≥65 | 1,971 (13.2) | 401 (20.4) | 0.88 (0.79, 0.98) | 0.90 (0.81, 1.00) |
Gender | ||||
Men | 10,715 (71.6) | 2,352 (22.0) | Ref | Ref |
Women | 4,241 (28.4) | 1,009 (23.8) | 1.08 (1.02, 1.16) | 1.03 (0.96, 1.10) |
Transgender | 5 (0.03) | 1 (20.0) | -- | |
Test used for diagnosis | ||||
Rapid molecular tests | 2,778 (18.6) | 840 (30.2) | 1.67 (1.55, 1.79) | 1.47 (1.36, 1.59)g |
Microscopy/culture | 8,015 (53.6) | 1,455 (18.2) |
Ref | Ref |
Chest radiograph | 1,546 (10.3) | 412 (26.7) | 1.47 (1.34, 1.61) | 1.24 (1.04, 1.47)g |
Others | 2,622 (17.5) | 655 (25.0) | 1.38 (1.27, 1.49) | 0.98 (0.81, 1.19) |
Microbiological confirmation | ||||
Yes | 11,333 (75.8) | 2,406 (21.2) | Ref | Ref |
No | 3,628 (24.3) | 956 (26.4) | 1.24 (1.16, 1.32) | 1.19 (0.99, 1.42) |
Site of TB | ||||
Pulmonary | 12,046 (80.5) | 2,361 (19.6) | Ref | Ref |
Extrapulmonary | 2,389 (16.0) | 640 (26.8) | 1.37 (1.27, 1.47) | 1.21 (1.09, 1.36)g |
Missing | 526 (3.5) | 361 (68.6) | 3.50 (3.27, 3.75) | 2.60 (2.36, 2.87)g |
Previous treatment | ||||
Yes | 1,606 (10.7) | 351 (21.9) | 0.97 (0.88, 1.07) | N/Ah |
No | 13,355 (89.3) | 3,011 (22.6) | Ref | |
HIV | ||||
Positive | 673 (4.5) | 194 (28.8) | 1.32 (1.17, 1.49) | 1.06 (0.93, 1.20) |
Negative | 14,161 (94.7) | 3,088 (21.8) | Ref | Ref |
Unknown | 127 (0.9) | 80 (63.0) | 2.89 (2.52, 3.31) | 1.03 (0.86, 1.23) |
DM | ||||
Positive | 3,823 (25.6) | 745 (19.5) | 0.88 (0.82, 0.95) | 0.94 (0.87, 1.91) |
Negative | 10,710 (71.6) | 2,374 (22.2) |
Ref | Ref |
Unknown | 38 (0.3) | 17 (44.7) | 2.02 (1.41, 2.88) | 1.28 (0.86, 1.91) |
Missing | 390 (2.6) | 226 (58.0) | 1.42 (1.23, 1.63)g | |
Peripheral health institute—notification facility | ||||
Primary | 2,372 (15.9) | 414 (17.5) | Ref | Ref |
Secondary | 5,970 (39.9) | 1,168 (19.6) | 1.12 (1.01, 1.24) | 0.98 (0.88, 1.08) |
Tertiary | 6,449 (43.1) | 1,710 (26.5) | 1.52 (1.38, 1.67) | 1.11 (1.01, 1.23)g |
Missing | 170 (1.1) | 70 (41.2) | 2.36 (1.93, 2.88) | 2.21 (1.83, 2.68)g |
Treatment started | ||||
Yes | 14,435 (96.5) | 3,001 (20.8) |
Ref | N/Ai |
No | 526 (3.5) | 361 (68.6) | 3.30 (3.09, 3.53) | |
Transferred out of district | ||||
Yes | 1,987 (13.3) | 670 (33.7) | 1.63 (1.51, 1.74) | 1.50 (1.40, 1.61)g |
No | 12,974 (86.7) | 2,692 (20.8) |
Ref | Ref |
Abbreviations: aPR, adjusted prevalence ratio; CI, confidence interval; DM, diabetes mellitus; PR, crude prevalence ratio; SeWA, Severe TB Web Application.
↵a Triaged defined as collecting and syncing of severity details in a mobile application irrespective of the extent of missing data.
↵b Aged 15 years and older.
↵c Source is the routinely collected baseline data in NIKSHAY and data updated in TB SeWA as of July 29, 2022.
↵d Column percentage.
↵e Row percentage.
↵f Modified Poisson regression with robust variance estimation; results have been adjusted for district.
↵g P<.05.
↵h Variables with crude P value ≥.05 (Chi square test) were not included in the adjusted analysis.
↵i Excluded because of variance inflation factor >10.